Problem

Anxiety and stress is not just a human problem

You and your furry best friend share more than love. Humans and pets have a very similar endocannabinoid system. Humans aren't the only creatures with anxiety. Severely traumatized rescue dogs need more than hands-on training to help to stabilize their moods. There are few, if any low-risk and effective ways to help animals manage their stress and maintain mental health.

The fast growing CBD trend is exposing itself to serious health concerns due to potential drug interactions and susceptibility to toxins. There is a lack of CBD education for human products and this lack is even more apparent for pet products.

Solution

Buzzn: CBD products to help you and your pets

Buzzn was created with one goal in mind: to help pets and their people live happy and healthy lives.

All of our high quality products come with complete ingredient and testing transparency. Our customers have daily access to our team of medical professionals regarding drug-drug interactions.

Buzzn is founded by subject matter experts in both human and pets products, driving two high growth product categories. Leveraging our founders’ and advisors’ unique backgrounds to develop products that takes care of you and your entire family. From pets to humans.

Product

Pharmacist created, Brooklyn born, Colorado grown

Our team of Pharmacists and healthcare professionals created pet and human CBD products that use organic farming practices to cultivate naturally-developed generic strains of industrial hemp for safe and regulated hemp oil products.

All products use toxin-free, broad-spectrum CBD hemp extract that is third-party lab tested for purity. In 2020, we will be developing a full-spectrum line of products.

All packaging is made from 50% post-consumer waste material and 100% recyclable paper.

For each pet product purchased, we donate a portion to support Korean K9 Rescue in their mission to ban the dog meat trade in Korea.

Top Selling Product - Online:

Puppy Potion

Top Selling Products - Retail:

Super Powered Healing Balm

Puppy Potion

Traction

60+ retail locations across 4 states in 1 year

We’ve seen incredible growth in just one year. Our products are now available in 4 states and over 60 retail locations. Aside from seeing retail and e-commerce growth, we have built a charitable partnership with Korean K9 Rescue to include our products with every adoption package.

We’ve been featured in a variety of publications and have quickly grown a reputation for ourselves as efficient, pure and healthy for humans and pets alike.

Pop-ups, events, and cross-promotional partners

In the press

Customers

Loved by pets and their humans

Buzzn was founded with the intention of reducing stress in pets. From the results that owners were seeing in their pets, we started getting many requests to create products to help the humans. So, we formulated a line specifically for humans. We take feedback seriously. We listen to our customers and strive to create products they want. All of our products have had a demonstrated impact on our customers - humans and pets alike.

Business model

Competitively priced, high quality products

Retail

Since our inception in Feb 2019, we have built strategic retail partnerships. Our retailer profit margin is an average of 65% across all products. We strongly support our retail partners through in-person and social media collaborations & giveaways.

Online (Direct-to-consumer)

Online presence is a must and we wanted a channel in which we can be accessible to everyone. First, with E-Wallet, and currently, with Square’s CBD Beta program, our pet and human products are available online at getbuzzn.com. Our D2C profit margin is an average of 84% across all products.

Market

Targeting multiple markets valued from $3B to $137B

Customers

There is a consumer age group overlap between millennial pet owners and adults that reported the highest level of CBD use.

CBD (Cannabidiol)

CBD products are rising in popularity thanks to greater awareness of its healing properties and pain relief management. In 2018, the global CBD market was valued at $4.6 Billion. This is expected to grow at a rate of 22.2%. According to industry reports, the health benefits of CBD infused products is expected to grow the market for years to come.

Pet Care

75% of millennials own a pet, and see their pets as the first "child". According to reports, "millennials are bringing pets into their household earlier than the previous generations. They delayed marriage, but those pets fill that void." In 2019, $95.7B was spent on pets in the U.S. with $36.9B spent on pet food and treats.

Topical (Skin care)

The CBD skin care market exhibits an incremental revenue opportunity of $2.7B from 2019 to 2026. CBD infused skin care products are gaining popularity among consumers due to its potential to relief common skin issue through its anti-inflammatory, anti-oxidant properties. It has also been touted to potentially help various inflammatory skin conditions such as eczema, psoriasis, and acne. Our Super Powered Healing Balm has been wildly successful as our only topical at the moment. For 2020, we are working to capture the skin care consumer by launching two new CBD skin care products.

Competition

Formulated with deep understanding of ingredient profiles

CBD (Cannabidiol) is not just a trend, CBD is an active ingredient. It has actual therapeutic effects on our bodies and brain receptors. It can also cause drug interactions with other compounds. Buzzn is unlike its competitors in that our products are all formulated and approved by a team of pharmacists and industry experts who have a deep understanding of the effects of CBD.

Unlike many of our competitors, Buzzn works alongside our community. Giving back to causes close to our hearts have always been the foundation of our brand.

Vision

Empowering a happier & healthier generation of people and pets

Being a year old, we have spent the last year listening to our customers and understanding what the market wants. We highly value the insights gained from last year to help build our brand.

By reaching our investment goal, Buzzn will continue to expand our online and offline presence in our sophomore year. With a more dynamic PR strategy, our goal is to expand into west coast retailers and introduce a new category of products—skin care.

Use of Funds:

Sales + Marketing:

Engage a more robust PR program to help drive new pet product launches and our skin care launch

Implement a stronger influencer program

Host / co-host more pop-ups and events with influential brands and influencers

Grow our family and bring a new sales associate onto the team to help maintain our retailer relationships

Community Involvement:

Continue to conduct and manage non-profit outreach in order to create more Giveback Programs for a variety of charitable causes

Product Development & Operations:

R&D / product development for skin care and pet products

Update current packaging and create new packaging for upcoming products

A SAFE is a Simple Agreement for Future Equity. An investor makes a cash investment in a company, but gets company stock at a later date, in connection with a specific event. The Crowd SAFE is a modified SAFE that is better suited for crowdfunding.

Funding goal

$25,000
–
$1,070,000

Buzzn
needs to raise
$25K
before the deadline.
The maximum amount
Buzzn
is willing to raise is
$1.07M.
Learn more

Deadline

Buzzn needs to reach their minimum funding goal before the deadline
().
If they don’t, all investments will be refunded.
Learn more

FAQ

What makes our CBD hemp different?

Buzzn products are created with natural proprietary strains of phytocannabinoid-rich hemp from Colorado. With a supercritical CO2 extraction process, we get an extract rich in terpenes, cannabidiol (CBD) and other phytocannabinoids. This extract is further subjected to winterization in ethanol and solvent removal through vacuum distillation. After the chlorophyll, waxes, and THC are removed, the resulting product is a PCR hemp oil with 70-90% CBD, minor cannabinoids, and terpenes.

Our CBD hemp is derived from 100% organic industrial hemp plants in Colorado. All of our farmers grow in full compliance with the Colorado Department of Agriculture’s Industrial Hemp Program. Buzzn products are safe, regulated, and unsurpassed in their potency and consistency. Our products are Pharmaceutical-Grade, manufactured in a GMP-certified facility by the FDA.

Risks

The Company is still in an early phase and is just beginning to implement its business plan. There can be no assurance that it will ever operate profitably. The likelihood of its success should be considered in light of the problems, expenses, difficulties, complications and delays usually encountered by companies in their early stages of development. The Company may not be successful in attaining the objectives necessary for it to overcome these risks and uncertainties.

In order to achieve the Company’s near and long-term goals, the Company may need to procure funds in addition to the amount raised in the Offering. There is no guarantee the Company will be able to raise such funds on acceptable terms or at all. If we are not able to raise sufficient capital in the future, we may not be able to execute our business plan, our continued operations will be in jeopardy and we may be forced to cease operations and sell or otherwise transfer all or substantially all of our remaining assets, which could cause a Purchaser to lose all or a portion of his or her investment.

The Company is dependent on certain key personnel in order to conduct its operations and execute its business plan, however, the Company has not purchased any insurance policies with respect to those individuals in the event of their death or disability. Therefore, if any of these personnel die or become disabled, the Company will not receive any compensation to assist with such person’s absence. The loss of such person could negatively affect the Company and its operations. We have no way to guarantee key personnel will stay with the Company, as many states do not enforce non-competition agreements, and therefore acquiring key man insurance will not ameliorate all of the risk of relying on key personnel.

The Company may not have the internal control infrastructure that would meet the standards of a public company, including the requirements of the Sarbanes Oxley Act of 2002. As a privately-held (non-public) Company, the Company is currently not subject to the Sarbanes Oxley Act of 2002, and it's financial and disclosure controls and procedures reflect its status as a development stage, non-public company. There can be no guarantee that there are no significant deficiencies or material weaknesses in the quality of the Company's financial and disclosure controls and procedures. If it were necessary to implement such financial and disclosure controls and procedures, the cost to the Company of such compliance could be substantial and could have a material adverse effect on the Company's results of operations.

The Company is subject to legislation and regulation at the federal and local levels and, in some instances, at the state level. [The FCC and/or Congress may attempt to change the classification of or change the way that our online content platforms are regulated and/or change the framework under which Internet service providers are provided Safe Harbor for claims of copyright infringement, introduce changes to how digital advertising is regulated and consumer information is handled, changing rights and obligations of our competitors.] We expect that court actions and regulatory proceedings will continue to refine our rights and obligations under applicable federal, state and local laws, which cannot be predicted. Modifications to existing requirements or imposition of new requirements or limitations could have an adverse impact on our business.

As an early-stage company, we may implement new lines of business at any time. There are substantial risks and uncertainties associated with these efforts, particularly in instances where the markets are not fully developed. In developing and marketing new lines of business and/or new products and services, we may invest significant time and resources. Initial timetables for the introduction and development of new lines of business and/or new products or services may not be achieved, and price and profitability targets may not prove feasible. We may not be successful in introducing new products and services in response to industry trends or developments in technology, or those new products may not achieve market acceptance. As a result, we could lose business, be forced to price products and services on less advantageous terms to retain or attract clients, or be subject to cost increases. As a result, our business, financial condition or results of operations may be adversely affected.

We are subject to extensive federal, state, local and foreign environmental, health and safety laws and regulations concerning matters such as air emissions, wastewater discharges, solid and hazardous waste handling and disposal and the investigation and remediation of contamination. The risks of substantial costs and liabilities related to compliance with these laws and regulations are an inherent part of our business, and future conditions may develop, arise or be discovered that create substantial environmental compliance or remediation liabilities and costs. Compliance with environmental, health and safety legislation and regulatory requirements may prove to be more limiting and costly than we anticipate. We may be subject to legal proceedings brought by private parties or governmental authorities with respect to environmental matters, including matters involving alleged property damage or personal injury. New laws and regulations, including those which may relate to emissions of greenhouse gases, stricter enforcement of existing laws and regulations, the discovery of previously unknown contamination or the imposition of new clean-up requirements could require us to incur costs or become the basis for new or increased liabilities that could have a material adverse effect on our business, financial condition or results of operations.

Our reputation and the quality of our brand are critical to our business and success in existing markets, and will be critical to our success as we enter new markets. Any incident that erodes consumer loyalty for our brand could significantly reduce its value and damage our business. We may be adversely affected by any negative publicity, regardless of its accuracy.
Also, there has been a marked increase in the use of social media platforms and similar devices, including blogs, social media websites and other forms of internet-based communications that provide individuals with access to a broad audience of consumers and other interested persons. The availability of information on social media platforms is virtually immediate as is its impact. Information posted may be adverse to our interests or may be inaccurate, each of which may harm our performance, prospects or business. The harm may be immediate and may disseminate rapidly and broadly, without affording us an opportunity for redress or correction.

You should not rely on the fact that our Form C is accessible through the U.S. Securities and Exchange Commission’s EDGAR filing system as an approval, endorsement or guarantee of compliance as it related to this Offering.

The securities being offered have not been registered under the Securities Act of 1933 (the "Securities Act"), in reliance, among other exemptions, on the exemptive provisions of article 4(2) of the Securities Act and Regulation D under the Securities Act. Similar reliance has been placed on apparently available exemptions from securities registration or qualification requirements under applicable state securities laws. No assurance can be given that any offering currently qualifies or will continue to qualify under one or more of such exemptive provisions due to, among other things, the adequacy of disclosure and the manner of distribution, the existence of similar offerings in the past or in the future, or a change of any securities law or regulation that has retroactive effect. If, and to the extent that, claims or suits for rescission are brought and successfully concluded for failure to register any offering or other offerings or for acts or omissions constituting offenses under the Securities Act, the Securities Exchange Act of 1934, or applicable state securities laws, the Company could be materially adversely affected, jeopardizing the Company's ability to operate successfully. Furthermore, the human and capital resources of the Company could be adversely affected by the need to defend actions under these laws, even if the Company is ultimately successful in its defense.
Compliance with the criteria for securing exemptions under federal securities laws and the securities laws of the various states is extremely complex, especially in respect of those exemptions affording flexibility and the elimination of trading restrictions in respect of securities received in exempt transactions and subsequently disposed of without registration under the Securities Act or state securities laws.

Unless the Company has agreed to a specific use of the proceeds from an offering, the Company's management will have considerable discretion over the use of proceeds from their offering. You may not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately.

The Company may prevent Purchasers from committing more than a certain amount to this Offering based on the Company’s belief of the Purchaser’s sophistication and ability to assume the risk of the investment. This means that your desired investment amount may be limited or lowered based solely on the Company’s determination and not in line with relevant investment limits set forth by the Regulation Crowdfunding rules. This also means that other Purchasers may receive larger allocations of the Offering based solely on the Company’s determination.

The Company may extend the Offering deadline beyond what is currently stated herein. This means that your investment may continue to be held in escrow while the Company attempts to raise the Minimum Amount even after the Offering deadline stated herein is reached. While you have the right to cancel your investment in the event the Company extends the Offering, if you choose to reconfirm your investment, your investment will not be accruing interest during this time and will simply be held until such time as the new Offering deadline is reached without the Company receiving the Minimum Amount, at which time it will be returned to you without interest or deduction, or the Company receives the Minimum Amount, at which time it will be released to the Company to be used as set forth herein. Upon or shortly after release of such funds to the Company, the Securities will be issued and distributed to you. The Company may also end the Offering early; if the Offering reaches its target Offering amount after 21-calendary days but before the deadline, the Company can end the Offering with 5 business day’s notice. This means your failure to participate in the Offering in a timely manner, may prevent you from being able to participate – it also means the Company may limit the amount of capital it can raise during the Offering by ending it early.

You should be aware of the long-term nature of this investment. There is not now and likely will not be a public market for the units of SAFE. Because the units of SAFE have not been registered under the Securities Act or under the securities laws of any state or non-United States jurisdiction, the units of SAFE have transfer restrictions and cannot be resold in the United States except pursuant to Rule 501 of Regulation CF. It is not currently contemplated that registration under the Securities Act or other securities laws will be affected. Limitations on the transfer of the units of SAFE may also adversely affect the price that you might be able to obtain for the units of SAFE in a private sale. Purchasers should be aware of the long-term nature of their investment in the Company. Each Purchaser in this Offering will be required to represent that it is purchasing the Securities for its own account, for investment purposes and not with a view to resale or distribution thereof.

Purchasers will not have an ownership claim to the Company or to any of its assets or revenues for an indefinite amount of time and depending on when and how the Securities are converted, the Purchasers may never become equity holders of the Company. Purchasers will not become equity holders of the Company unless the Company receives a future round of financing great enough to trigger a conversion and the Company elects to convert the Securities into CF Shadow Series Securities. The Company is under no obligation to convert the Securities into CF Shadow Securities (the type of equity Securities Purchasers are entitled to receive upon such conversion). In certain instances, such as a sale of the Company or substantially all of its assets, an IPO or a dissolution or bankruptcy, the Purchasers may only have a right to receive cash, to the extent available, rather than equity in the Company.

Purchasers will not have the right to vote upon matters of the Company even if and when their Securities are converted into CF Shadow Securities (which the occurrence of cannot be guaranteed). Upon such conversion, CF Shadow Securities will have no voting rights and even in circumstances where a statutory right to vote is provided by state law, the CF Shadow Security holders are required to enter into a proxy agreement with the Intermediary ensuring they will vote with the majority of the security holders in the new round of equity financing upon which the Securities were converted. For example, if the Securities are converted upon a round offering Series B Preferred Shares, the Series B-CF Shadow Security holders will be required to enter into a proxy that allows the Intermediary to vote the same way as a majority of the Series B Preferred Shareholders vote. Thus, Purchasers will never be able to freely vote upon any manager or other matters of the Company.

Purchasers will not have the right to inspect the books and records of the Company or to receive financial or other information from the Company, other than as required by Regulation CF. Other security holders of the Company may have such rights. Regulation CF requires only the provision of an annual report on Form C and no additional information – there are numerous methods by which the Company can terminate annual report obligations, resulting in no information rights, contractual, statutory or otherwise, owed to Purchasers. This lack of information could put Purchasers at a disadvantage in general and with respect to other security holders.

Unlike convertible notes and some other securities, the Securities do not have any "default" provisions upon which the Purchasers will be able to demand repayment of their investment. The Company has ultimate discretion as to whether or not to convert the Securities upon a future equity financing and Purchasers have no right to demand such conversion. Only in limited circumstances, such as a liquidity event, may the Purchasers demand payment and even then, such payments will be limited to the amount of cash available to the Company.

The Company may never receive a future equity financing or elect to convert the Securities upon such future financing. In addition, the Company may never undergo a liquidity event such as a sale of the Company or an IPO. If neither the conversion of the Securities nor a liquidity event occurs, the Purchasers could be left holding the Securities in perpetuity. The Securities have numerous transfer restrictions and will likely be highly illiquid, with no secondary market on which to sell them. The Securities are not equity interests, have no ownership rights, have no rights to the Company’s assets or profits and have no voting rights or ability to direct the Company or its actions.
In addition to the risks listed above, businesses are often subject to risks not foreseen or fully appreciated by the management. It is not possible to foresee all risks that may affect us. Moreover, the Company cannot predict whether the Company will successfully effectuate the Company’s current business plan. Each prospective Purchaser is encouraged to carefully analyze the risks and merits of an investment in the Securities and should take into consideration when making such analysis, among other, the Risk Factors discussed above.

Company equity securities will be subject to dilution. Company intends to issue additional equity to employees and third-party financing sources in amounts that are uncertain at this time, and as a consequence holders of equity securities resulting from SAFE conversion will be subject to dilution in an unpredictable amount. Such dilution may reduce the purchaser’s control and economic interests in the Company.
The amount of additional financing needed by Company will depend upon several contingencies not foreseen at the time of this offering. Each such round of financing (whether from the Company or other investors) is typically intended to provide the Company with enough capital to reach the next major corporate milestone. If the funds are not sufficient, Company may have to raise additional capital at a price unfavorable to the existing investors, including the purchaser. The availability of capital is at least partially a function of capital market conditions that are beyond the control of the Company. There can be no assurance that the Company will be able to predict accurately the future capital requirements necessary for success or that additional funds will be available from any source. Failure to obtain such financing on favorable terms could dilute or otherwise severely impair the value of the purchaser’s Company securities.

Company may issue to converting SAFE holders equity securities that are materially distinct from equity securities it will issue to new purchasers of equity securities. This paragraph does not purport to be a complete summary of all such distinctions. Equity securities issued to SAFE purchasers upon their conversion of Company SAFE securities will be distinct from the equity securities issued to new purchasers in at least the following respects - to the extent such equity securities bear any liquidation preferences, dividend rights, or anti-dilution protections, any equity securities issued at the Conversion Price (as provided in the SAFE Agreements) shall bear such preferences, rights, and protections only in proportion to the Conversion Price and not in proportion to the price per share paid by new investors in the equity securities. Company may not provide converting SAFE purchasers the same rights, preferences, protections, and other benefits or privileges provided to other purchasers of Company equity securities.

The offering price was not established in a competitive market. We have arbitrarily set the price of the Securities with reference to the general status of the securities market and other relevant factors. The Offering price for the Securities should not be considered an indication of the actual value of the Securities and is not based on our net worth or prior earnings. We cannot assure you that the Securities could be resold by you at the Offering price or at any other price.

In a dissolution or bankruptcy of the Company, Purchasers of Securities which have not been converted will be entitled to distributions as described in the Crowd SAFE. This means that such Purchasers will be at the lowest level of priority and will only receive distributions once all creditors as well as holders of more senior securities, including any preferred stock holders, have been paid in full. If the Securities have been converted into CF Shadow Share Securities or SAFE Preferred Securities, the Purchasers will have the same rights and preferences (other than the ability to vote) as the holders of the Securities issued in the equity financing upon which the Securities were converted. Neither holders of Crowd SAFE nor holders of CF Shadow Share Securities nor SAFE Preferred Securities can be guaranteed a return in the event of a dissolution event or bankruptcy.

In certain events provided in the Crowd SAFE, holders of the Crowd SAFE may be entitled to a return of their principal amount. Despite the contractual provisions in the Crowd SAFE, this right cannot be guaranteed if the Company does not have sufficient liquid assets on hand. Therefore potential purchasers should not assume that they are guaranteed a return of their investment amount.

This site (the "Site") is owned and maintained by OpenDeal Inc., which is not a registered
broker-dealer. OpenDeal Inc. does not give investment advice, endorsement, analysis or
recommendations with respect to any securities. All securities listed here are being offered
by, and all information included on this Site is the responsibility of, the applicable issuer
of such securities. The intermediary facilitating the offering will be identified in such
offering’s documentation.

All funding-portal activities are conducted by OpenDeal Portal LLC doing business as Republic,
a funding portal which is registered with the US Securities and Exchange Commission (SEC) as a
funding portal (Portal) and is a member of the Financial Industry Regulatory Authority (FINRA).
OpenDeal Portal LLC is located at 335 Madison Avenue, Suite 7E, New York, NY 10017, please
check out background on FINRA’s
Funding Portal page.

All broker-dealer related securities activity is conducted by OpenDeal Broker LLC, an
affiliate of OpenDeal Inc. and OpenDeal Portal LLC, and a registered broker-dealer, and member
of
FINRA
|
SiPC,
located at 1345 Avenue of the Americas, 15th Floor, New York, NY 10105, please check our
background on FINRA’s
BrokerCheck.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC make investment
recommendations and no communication, through this Site or in any other medium should be
construed as a recommendation for any security offered on or off this investment platform.
Investment opportunities posted on this Site are private placements of securities that are
not publicly traded, involve a high degree of risk, may lose value, are subject to holding
period requirements and are intended for investors who do not need a liquid investment. Past
performance is not indicative of future results. Investors must be able to afford the loss
of their entire investment. Only qualified investors, which may be restricted to only
Accredited Investors or non-U.S. persons, may invest in offerings hosted by OpenDeal Broker.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC, nor any of their
officers, directors, agents and employees makes any warranty, express or implied, of any
kind whatsoever related to the adequacy, accuracy or completeness of any information on this
Site or the use of information on this site. Offers to sell securities can only be made
through official offering documents that contain important information about the investment
and the issuers, including risks. Investors should carefully read the offering documents.
Investors should conduct their own due diligence and are encouraged to consult with their
tax, legal and financial advisors.

Investors should verify any issuer information they consider important before making
an investment.

Investments in private companies are particularly risky and may result in total loss of
invested capital. Past performance of a security or a company does not guarantee future
results or returns. Only investors who understand the
risks of early stage investment
and who meet the Republic's
investment criteria
may invest.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC verify
information provided by companies on this Site and makes no assurance as to the completeness
or accuracy of any such information. Additional information about companies fundraising on
the Site can be found by searching the
EDGAR database,
or the offering documentation located on the Site when the offering does not require an
EDGAR filing.